VIVUS, Inc. (NASDAQ:VVUS)’s shares declined 0.43% to $4.68. The company on May 19 announced that a poster describing results of a clinical study examining onset of action of avanafil will be presented during the American Urological Association Annual Meeting in Orlando, FL. VIVUS, Inc. (NASDAQ:VVUS), weekly performance is -11.88%. On last trading day company shares ended up $4.60. Analysts mean target price for the company is $7.33. VIVUS, Inc. (NASDAQ:VVUS), distance from 50-day simple moving average (SMA50) is -15.30%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), was the target of some unusual options trading on Friday. Stock investors purchased 15,455 call options on the stock, American Banking & Market News reports. This is an increase of approximately 334% compared to the average daily volume of 3,558 call options. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), fell 2.69% in last trading session and ended the day on $6.33. ARNA, Gross Margin is 93.70% and its return on assets is -8.10%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), quarterly performance is -5.66%.
On May 14, 2014, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), announced that clinical data on Iclusig (ponatinib) and AP26113, its investigational oral inhibitor of anaplastic lymphoma kinase (ALK), will be presented at the Annual Meeting of the American Society of Clinical Oncology being held in Chicago, May 30 to June 3, 2014. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), shares moved down 3.64% in last trading session and was closed at $6.36, while trading in range of $6.33 – 6.62. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), year to date (YTD) performance is -6.74%.
On May 12, 2014, MannKind Corporation (NASDAQ:MNKD), reported its Q1 2014 financial results. Net loss applicable to common stockholders were $52.1 million, or $0.14 per diluted share, compared to $41.0 million, or $0.15 per diluted share in Q1 2013. Research and development (R&D) expenses were $26.2 million, compared to $26.4 million in Q1 2013. No revenues were reported for the quarter by the Company. As of March 31, 2014, the Company had cash and cash equivalents of $35.8 million. MannKind Corporation (NASDAQ:MNKD), ended the last trading day at $7.57. Company weekly volatility is calculated as 6.22% and price to cash ratio as 82.17. MannKind Corporation (NASDAQ:MNKD), showed a positive weekly performance of 15.05%.
Bayer AG (ADR) (OTCMKTS:BAYRY), released its earnings data on Tuesday. The company reported $2.35 earnings per share for the quarter, missing the analysts’ consensus estimate of $2.47 by $0.12, Analyst Ratings Network reports. Bayer AG (ADR) (OTCMKTS:BAYRY), on last trading day company shares ended up $34.80. Analysts mean target price for the company is $34.27.
Leave a Reply